EFNS guidelines on the use of neuroimaging in the management of motor neuron diseases.
about
What does imaging reveal about the pathology of amyotrophic lateral sclerosis?G-CSF prevents the progression of structural disintegration of white matter tracts in amyotrophic lateral sclerosis: a pilot trialComprehensive evaluation of corticospinal tract metabolites in amyotrophic lateral sclerosis using whole-brain 1H MR spectroscopy.T₂-weighted MRI detects presymptomatic pathology in the SOD1 mouse model of ALS.Widespread grey matter pathology dominates the longitudinal cerebral MRI and clinical landscape of amyotrophic lateral sclerosis.Mechanisms, models and biomarkers in amyotrophic lateral sclerosisA Systematic Review and Meta-Analysis of the Functional MRI Investigation of Motor Neuron DiseaseNew considerations in the design of clinical trials for amyotrophic lateral sclerosisAdvances in the application of MRI to amyotrophic lateral sclerosis.Biomarkers in amyotrophic lateral sclerosis: opportunities and limitations.Spinal cord markers in ALS: diagnostic and biomarker considerations.Amyotrophic Lateral Sclerosis and Metabolomics: Clinical Implication and Therapeutic Approach.MRI as a frontrunner in the search for amyotrophic lateral sclerosis biomarkers?Computer-based magnetic resonance imaging as a tool in clinical diagnosis in neurodegenerative diseases.Further development of biomarkers in amyotrophic lateral sclerosis.Neuroimaging of motor neuron diseases.Cerebral Degeneration in Amyotrophic Lateral Sclerosis Revealed by 3-Dimensional Texture AnalysisMultimodal structural MRI in the diagnosis of motor neuron diseasesMagnetic resonance imaging in amyotrophic lateral sclerosis.Quantitative FLAIR MRI in Amyotrophic Lateral SclerosisConcomitant amyotrophic lateral sclerosis and paraclinical laboratory features of multiple sclerosis: coincidence or causal relationship?Semiautomated Evaluation of the Primary Motor Cortex in Patients with Amyotrophic Lateral Sclerosis at 3T.Detecting neuronal dysfunction of hand motor cortex in ALS: A MRSI study.Value of quantitative analysis of routine clinical MRI sequences in ALS.Diffusion tensor imaging in amyotrophic lateral sclerosis--increased sensitivity with optimized region-of-interest delineation.Association between structural and functional corticospinal involvement in amyotrophic lateral sclerosis assessed by diffusion tensor MRI and triple stimulation techniqueNeuroimaging in amyotrophic lateral sclerosisThe El Escorial criteria: Strengths and weaknesses
P2860
Q27007017-460DA178-586E-46A8-BF7F-6DFE1B994E95Q28477416-29BD354A-03CD-46BE-BD2E-6BB76D5F0451Q31060094-FE8E3F37-116F-429D-8D12-8495E179E7DBQ33581148-9080BDF9-A4F9-4932-95B7-D55B46EB2A91Q34044019-113F2267-84C1-4B0D-95F8-8AB429FA2864Q34344992-0BDAA5A0-FEDE-420B-A4EC-BE93C162C57CQ35860707-6E5C9D2C-91BA-4D6D-BE97-50653F2F8D8CQ35910744-9137B069-DC02-49F2-A631-73CB08C5E598Q37868435-46B9A4C3-F1F7-4B35-9EBD-6F8CB9B4F525Q37944427-4859836B-5E58-4A92-A79C-6BE9A1EAD065Q37983648-1C655504-FB15-429D-8178-B727AB0ACE73Q38575783-284D2B51-F417-4615-A3F8-CD6DCEB40B37Q38587524-BC099AFE-ECB3-4806-A493-141D5CA446D9Q38710593-B32DEFD8-4303-46CF-8CB9-C1C225226730Q38856405-7961C9D5-9FCC-46DA-9B68-287B3B6D31EFQ39638383-A878CC03-D949-43FF-98F8-68F3F11650B8Q39638904-567371FA-586C-414A-8DD2-FA41362D68FEQ41272501-DEE1BD8A-4895-464A-A705-661487517C27Q42242501-013275AC-DC82-4012-B55D-48A5C4BC0129Q42360934-EAA0902A-F52F-4F6C-9525-D8CA6AAC681EQ43117005-42659DCB-002A-47F9-B2CA-1849D631250AQ48331848-6187C739-2448-4737-87A6-15B46784278FQ48343790-E88016C6-5AA8-46E4-93EA-A57FEDA2419FQ48966577-ADA341B5-FD81-4A74-A5E4-58D5CE10A5E7Q51218315-2F49D514-372F-422E-AB6B-1F6745D8F025Q57274212-A77230D6-1CDE-43FC-83E4-5427C24B211CQ57498892-F2A9B60C-3691-420A-A18B-87F3A16E97A3Q57911703-9E2F7FCD-800E-4B17-BFB4-8F2F4C9C5950
P2860
EFNS guidelines on the use of neuroimaging in the management of motor neuron diseases.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
EFNS guidelines on the use of neuroimaging in the management of motor neuron diseases.
@en
type
label
EFNS guidelines on the use of neuroimaging in the management of motor neuron diseases.
@en
prefLabel
EFNS guidelines on the use of neuroimaging in the management of motor neuron diseases.
@en
P2093
P2860
P50
P1476
EFNS guidelines on the use of neuroimaging in the management of motor neuron diseases.
@en
P2093
J C Masdeu
J Grosskreutz
S Abrahams
P2860
P304
P356
10.1111/J.1468-1331.2010.02951.X
P50
P577
2010-02-02T00:00:00Z